Cargando…

Is re-radiation for glioblastoma after progression associated with increased survival: to treat or not to treat?

Detalles Bibliográficos
Autores principales:	Carrillo, Jose A., Kesari, Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798780/ https://www.ncbi.nlm.nih.gov/pubmed/35116726 http://dx.doi.org/10.21037/tcr.2018.10.22

Ejemplares similares

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
por: Tieu, Minh Thi, et al.
Publicado: (2015)

Survival of glioblastoma treated with a moderately escalated radiation dose—Results of a retrospective analysis
por: Shieh, Li-Tsun, et al.
Publicado: (2020)

Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy
por: Eoli, Marica, et al.
Publicado: (2019)

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
por: Crawford, John, et al.
Publicado: (2020)

Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients
por: Koch, Cameron J., et al.
Publicado: (2014)

Longitudinal MRI evidence for decreased survival among periventricular glioblastoma
por: Young, Geoffrey S., et al.
Publicado: (2010)

Mouse models of radiation-induced glioblastoma
por: Mukherjee, Bipasha, et al.
Publicado: (2015)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Roh, Tae Hoon, et al.
Publicado: (2020)

Treating patients with ReSPECT during a pandemic: Resuscitation decisions during COVID-19
por: Field, Richard A., et al.
Publicado: (2021)

IMPACT OF NEUROTROPIC VIRUSES ON SURVIVAL OF PATIENTS WITH SURGICALLY TREATED GLIOBLASTOMA
por: Koruga, Nenad, et al.
Publicado: (2022)

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
por: Rulseh, Aaron Michael, et al.
Publicado: (2012)

Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
por: Grewal, Jai, et al.
Publicado: (2008)

To Treat or Not to Treat
por: Lee, Yeh Chen, et al.
Publicado: (2019)

Advances in treating glioblastoma
por: Weathers, Shiao-Pei, et al.
Publicado: (2014)

Survival of patients treated with radiation therapy for anaplastic astrocytoma
por: Barker, Christopher A., et al.
Publicado: (2014)

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy
por: Syed, Mustafa, et al.
Publicado: (2018)

Tumor treating fields increases membrane permeability in glioblastoma cells
por: Chang, Edwin, et al.
Publicado: (2018)

WNT Signaling as a Therapeutic Target for Glioblastoma
por: Latour, Michael, et al.
Publicado: (2021)

Factors Associated with Increased Survival after Surgical Resection of Glioblastoma in Octogenarians
por: Abdullah, Kalil G., et al.
Publicado: (2015)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Subventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012
por: Murchison, Sonja C, et al.
Publicado: (2018)

Post-radiation sarcoma of the neck treated with re-irradiation followed by wide excision
por: Tan, Alex, et al.
Publicado: (2006)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
por: Capper, David, et al.
Publicado: (2017)

A community affair in the tumor microenvironment
por: Rodvold, Jeffrey J., et al.
Publicado: (2017)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8(+) T cell activation in the presence of adjuvant temozolomide
por: Pellegatta, Serena, et al.
Publicado: (2018)

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2018)

Case report: tumor-treating fields prolongs IDH-mutant anaplastic astrocytoma progression-free survival and pathological evolution to glioblastoma
por: Lin, Yi, et al.
Publicado: (2021)

Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide
por: Brawanski, Konstantin R., et al.
Publicado: (2023)

A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
por: Otto-Meyer, Sebastian, et al.
Publicado: (2019)

Potential improvement of survival statistics for glioblastoma multiforme (WHO IV)
por: Goldsmith, Harry S.
Publicado: (2019)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021)

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
por: Stachelek, Gregory C., et al.
Publicado: (2019)

Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
Publicado: (2022)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Current Challenges and Opportunities in Treating Glioblastoma
por: Shergalis, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_99v4s38buodd35122gfsb1svl8